This partial bibliography of studies is provided for informational purposes only. It should not be considered to replace medical advice from your physician, nor should it be considered as a list of every existing study on this topic. The ANR Foundation is unable to provide copies of any of the studies. Links to either the study’s abstract or full text are provided when available. The citations referenced below are presented without comment regarding the source, including any potential conflict of interest. Due diligence is recommended in researching the source of any given study before relying on its conclusions.
Braznell, S.; Branston, J.R.; Gilmore, A.B., “Corporate communication of the relative health risks of IQOS through a webchat service,” Tobacco Control 32(e2): e205-e211, August 2023.
Page, M.K.; Paul, E.E.; Leigh, N.J.; Meza, L.R.; Galimov, A.; Sussman, S.; Leventhal, A.; O’Connor, R.J.; Goniewicz, M.L., “Still ‘cool’: tobacco industry responds to state-wide menthol ban with synthetic coolants,” Tobacco Control [Online ahead of print] July 27, 2023.
Matthes, B.K., Kumar, P., Dance, S. et al., “Advocacy counterstrategies to tobacco industry interference in policymaking: a scoping review of peer-reviewed literature,” Global Health 19: 42, June 21, 2023.
McDonald, A.; McCausland, K.; Thomas, L.; Daube, M.; Jancey, J., “Smoke and mirrors? Conflict of interest declarations in tobacco and e-cigarette-related academic publications,” Australian and New Zealand Journal of Public Health [Online ahead of print], May 16, 2023.
Legg, T.; Clift, B.; Gilmore, A.B., “Document analysis of the Foundation for a Smoke-Free World’s scientific outputs and activities: a case study in contemporary tobacco industry agnogenesis,” Tobacco Control [Online ahead of print], May 3, 2023.
Lee, J.G.L.; Soule, E.K., “Evidence of potential tobacco industry influence in Tobacco Regulatory Science,” Tobacco Control 32(3): 400-401, May 2023.
Matthes, B.K.; Fabbri, A.; Dance, S.; Lawrence, L.; Silver, K.; Gilmore, A.B., “Seeking to be seen as legitimate members of the scientific community? An analysis of British American Tobacco and Philip Morris International’s involvement in scientific events,” Tobacco Control [Online ahead of print], February 3, 2023.
Gray, N., et al., “2023 Tobacco industry interference index,” Washington, DC: Action on Smoking and Health (ASH), 2023. *ANRF fact sheets
Burki, T.K., “25 organisations added to tobacco industry allies database,” Lancet Oncology 23(12): 1493, December 2022.
Pattemore, P.; Edwards, R., “Tobacco company funding and conflict of interest,” Lancet 400(10349): 356, July 30, 2022.
Miller, J.; Vijayaraghavan, M., “Tobacco industry efforts to respond to smoke-free policies in multi-unit housing: an evaluation of tobacco industry documents,” International Journal of Environmental Research and Public Health 19(5): 3053, March 5, 2022.
Briggs, J.; Vallone, D., “The tobacco industry’s renewed assault on science: a call for a united public health response,” American Journal of Public Health 112(3): 388-390, March 2022.
Hoe, C.; Weiger, C.; Minosa, M.K.R.; Alonso, F.; Koon, A.D.; Cohen, J.E., “Strategies to expand corporate autonomy by the tobacco, alcohol and sugar-sweetened beverage industry: a scoping review of reviews,” Globalization and Health 18: 17, February 14, 2022.
Levy, D.T.; Liber, A.C.; Cadham, C.; Sanchez-Romero, L.M.; Hyland, A.; Cummings, M.; Douglas, C.; Meza, R.; Henriksen, L., “Follow the money: a closer look at US tobacco industry marketing expenditures,” Tobacco Control [Online ahead of print], January 24, 2022.
Gratale, S.K.; Ganz, O.; Wackowski, O.A.; Lewis, M.J., “Naturally leading: a content analysis of terms, themes and word associations in Natural American Spirit advertising, 2000–2020,” Tobacco Control [Online ahead of print], January 12, 2022.
Ma, H.; Reimold, A.E.; Ribisl, K.M., “Trends in cigarette marketing expenditures, 1975-2019: an analysis of Federal Trade Commission cigarette reports,” Nicotine and Tobacco Research [Online ahead of print], January 5, 2022.
Heley, K.; Popova, L.; Moran, M.B.; Ben Taleb, Z.; Hart, J.L.; Wackowski, O.A.; Westling, E.; Smiley, S.L.; Stanton, C.A., “Targeted tobacco marketing in 2020: the case of #BlackLivesMatter,” Tobacco Control [Online ahead of print], December 14, 2021.
Dewhirst, T., “‘Beyond nicotine’ marketing strategies: Big Tobacco diversification into the vaping and cannabis product sectors,” Tobacco Control [Online ahead of print], September 12, 2021.
Cohen, J.E.; Gilmore, A.B.; Legg, T.; Laurence, L.; Eissenberg, T; Connie Hoe, L., “The Foundation for a Smoke-Free World—even less independent from its tobacco company funder,” BMJ [Online ahead of print], August 10, 2021.
Burki, T.K., “Tobacco industry capitalises on the COVID-19 pandemic,” Lancet Respiratory Medicine [Online ahead of print], July 29, 2021.
Kennedy, T.; Gray, N.; Ballweg, G., “Editorial: mobilizing to overcome tobacco industry interference in lawmaking,” Tobacco Induced Diseases 19: 45, June 2021.
Legg, T.; Legendre, M.; Gilmore, A.B., “Paying lip service to publication ethics: scientific publishing practices and the Foundation for a Smoke-Free World,” Tobacco Control [Online ahead of print], April 28, 2021.
Ayers, J.W.; Leas, E.C.; Dredze, M.; Caputi, T.L.; Zhu, S.; Cohen, J.E., “Philip Morris International used the e-cigarette, or vaping, product use associated lung injury (EVALI) outbreak to market IQOS heated tobacco,” Tobacco Control [Online ahead of print], April 16, 2021.
Stevens, E.M.; Hébert, E.T.; Keller-Hamilton, B.; Frank-Pearce, S.G.; Tackett, A.P.; Leshner, G.; Wagener, T.L., “Associations between exposure to the real cost campaign, pro-tobacco advertisements, and tobacco use among youth in the U.S.,” American Journal of Preventive Medicine [Online ahead of print], February 11, 2021.
Sircar, N.R.; Glantz, S.A., “Defeating Juul’s effort to rewrite San Francisco’s e-cigarette regulations,” American Journal of Public Health [Online ahead of print], January 21, 2021.
Watts, C.; Burton, S.; Freeman, B., “Creating a market for IQOS: analysis of Philip Morris’ strategy to introduce heated tobacco products to the Australian consumer market,” Tobacco Control [Online ahead of print], November 15, 2020.
Waa, A.; Maddox, R.; Nez Henderson, P., “Big Tobacco using Trojan Horse tactics to exploit Indigenous peoples,” Tobacco Control [Online ahead of print], May 30, 2020.
Lewis, M.J.; Ackerman, C.; Ling, P., “‘Being politically active does not have to be difficult’: a content analysis of tobacco industry-sponsored advocacy websites,” Tobacco Control [Online ahead of print], April 20, 2020.
Waa, A.; Robson, B.; Gifford, H.; Smylie, J.; Reading, J.; Henderson, J.A.; Nez Henderson, P.; Maddox, R.; Lovett, R.; Eades, S.; Finlay, S.; Calma, T., “Foundation for a Smoke-Free World and healthy Indigenous futures: an oxymoron?,” Tobacco Control 29(2): 237-240, March 2020.
Escobedo, P.; Tsai, K.Y.; Majmundar, A.; Allem, J.P.; Soto, D.W.; Pattarroyo, M.; Unger, J.B.; Cruz, T.B., “Do tobacco industry websites target content to specific demographic groups?,” Drug and Alcohol Dependence [Online ahead of print], January 17, 2020.
Crosbie, E.; Schmidt, L.A., “Preemption in tobacco control: a framework for other areas of public health,” American Journal of Public Health [Online ahead of print], January 16, 2020.
van der Eijk, Y.; Bero, L.A.; Malone, R.E., “Philip Morris International-funded ‘Foundation for a Smoke-Free World’: analysing its claims of independence,” Tobacco Control 28(6): 712-718, November 2019.
Risi, S.; Proctor, R.N., “Big tobacco focuses on the facts to hide the truth: an algorithmic exploration of courtroom tropes and taboos,” Tobacco Control [Online ahead of print], September 13, 2019.
[n.a.], “Philip Morris International: money over morality?” Lancet 394(10200): 709, August 31, 2019.
Legg, T.; Peeters, S.; Chamberlain, P.; Gilmore, A.B., “The Philip Morris-funded Foundation for a Smoke-Free World: tax return sheds light on funding activities,” The Lancet 393(10190): 2487-2488, June 22, 2019.
Bero, L., “Ten tips for spotting industry involvement in science policy,” Tobacco Control 28(1): 1-2, January 2019.
Liu, J.; Halpern-Felsher, B., “The Juul curriculum is not the jewel of tobacco prevention education,” Journal of Adolescent Health 63(5): 527-528, November 2018.
Herrera, A.L.; Kreitzberg, D.S.; Loukas, A.; Pasch, K.E., “Tobacco-free but not tobacco industry free,” Tobacco Control
27(6): 716, November 2018.
Elias, J.; Ling, P.M., “Invisible smoke: third-party endorsement and the resurrection of heat-not-burn tobacco products,” Tobacco Control 27(Suppl.1): s96-s101, November 2018.
Schwartz, R.; Chaiton, M.; Borland, T.; Diemert, L., “Tobacco industry tactics in preparing for menthol ban,” Tobacco Control 27(5): 577, September 2018.
Ling, P.M.; Glantz, S.A., “Tobacco company strategies to identify and promote the benefits of nicotine,” Tobacco Control [Online ahead of print], August 9, 2018.
Whitlatch, A.; Schick, S., “Thirdhand smoke at Philip Morris,”
Nicotine and Tobacco Research [Online ahead of print]. July 20, 2018.
D’Silva, J.; O’Gara, E.; Villaluz, N.T., “Tobacco industry misappropriation of American Indian culture and traditional tobacco,” Tobacco Control 27(e1): e57-e64, July 2018.
van der Eijk, Y.; Bialous, S.; Glantz, S., “The tobacco industry and children’s rights,” Pediatrics 141(5): e20174106, April 2018.
van der Eijk, Y.; Glantz, S.A., “Tobacco industry attempts to frame smoking as a ‘disability’ under the 1990 Americans with Disabilities Act,” PLOS One 12(11): e0188188, November 27, 2017.
Daube, M.; Moodie, R.; McKee, M., “Towards a smoke-free world? Philip Morris International’s new foundation is not credible,” Lancet 390(10104): 1722-1724, October 14, 2017.
Yach, D., “Foundation for a Smoke-Free World,” Lancet 390(10104): 1807-1810, October 14, 2017.
Crosbie, E.; Gonzalez, M.; Glantz. S.A., “Health preemption behind closed doors: trade agreements and fast-track authority,” American Journal of Public Health [Online ahead of print], July 17, 2014.
Peeters, S.; Gilmore, A.B., “Understanding the emergence of the tobacco industry’s use of the term tobacco harm reduction in order to inform public health policy,” Tobacco Control [Online ahead of print], January 22, 2014.
Fooks, G.J.; Gilmore, A.B., “Corporate philanthropy, political influence, and health policy,” PLOS One [Online ahead of print], November 27, 2013.
Clifford, D.; Hill, S.; Collin, J., “Seeking out ‘easy targets’? Tobacco companies, health inequalities and public policy,” Tobacco Control [Online ahead of print], July 5, 2013.
Tan, C.E.; Kyriss, T.; Glantz, S.A., “Tobacco company efforts to influence the Food and Drug Administration-commissioned Institute of Medicine report Clearing the Smoke: an analysis of documents released through litigation,” PLoS Medicine 10(5): e1001450, May 2013.
Iglesias-Rios, L.; Parascandola, M., “A historical review of R.J. Reynolds’ strategies for marketing tobacco to hispanics in the United States,” American Journal of Public Health 103(5): e15-e27, May 2013.
Smith, K.E.; Savell, E.; Gilmore, A.B., “What is known about tobacco industry efforts to influence tobacco tax? A systematic review of empirical studies,” Tobacco Control 22(2): 144-153, March 2013.
Hiilamo, H.; Glantz, S.A., “Local Nordic tobacco interests collaborated with multinational companies to maintain a united front and undermine tobacco control policies,” Tobacco Control 22(2): 154-164, March 2013.
Hopkinson, N.S.; Moxham, J.; Montgomery, H.; West, R.; Scally, G.; McKee, M.; Spiro, S.; Bush, A.; Stradling, J.; Wells, A.; Chung, K.F.; Durham, S.R.; Martin, F.C.; Congleton, J.; Roddy, E.; Dayer, M.; White, P.; Ind, P.W.; Brown, J.L.; Patel, I.; Lewis, K.; Hart, N.; Kemp, S.; Barker, J.; Hind, M.; Nicholl, D.; Stern, M.; Elkin, S., “Tobacco industry lobbyists and their health-care clients,” Lancet 381(9865): 445, February 9, 2013.
Fallin, A.; Grana, R.; Glantz, S.A., “‘To quarterback behind the scenes, third-party efforts’: the tobacco industry and the Tea Party,” Tobacco Control [Online ahead of print], February 8, 2013.
Kennedy, R.D.; Millstein, R.A.; Rees, V.A., Connolly, G.N., “Tobacco industry strategies to minimize or mask cigarette smoke:
opportunities for tobacco product regulation,” Nicotine and Tobacco Research 15(2): 596-602, February 2013.
Givel, M., “Campaign to counter a deteriorating consumer market: Philip Morris’s Project Sunrise,” Public Health [Online ahead of print], January 22, 2013.
Kennedy, R.D.; Millstein, R.A.; Rees, V.W.; Connolly, G.N., “Tobacco industry strategies to minimize or mask cigarette smoke: opportunities for tobacco product regulation,” Nicotine and Tobacco Research [Online ahead of print], September 4, 2012.
Kyriss, T.; Schneider, N.K., “The development of scientific consultants: how the tobacco industry creates controversy on the carcinogenicity of tobacco-specific nitrosamines,” Tobacco Control [Online ahead of print], September 2, 2012.
Lee, S.; Ling, P.M.; Glantz, S.A., “The vector of the tobacco epidemic: tobacco industry practices in low and middle-income countries,” Cancer Causes Control [Online ahead of print], February 28, 2012.
Brandt, A.M., “Inventing conflicts of interest: a history of tobacco industry tactics,” American Journal of Public Health 102(1): 63-71, January 2012.
Gruning, T.; Weishaar, H.; Collin, J.; Gilmore, A.B., “Tobacco industry attempts to influence and use the German government to undermine the WHO Framework Convention on Tobacco Control,” Tobacco Control 21(1): 30-38, January 2012.
Gonzales, M.; Glantz, S.A., “Failure of policy regarding smoke-free bars in the Netherlands,” European Journal of Public Health [Online ahead of print], December 5, 2011.
Daube, M.; Bond, L.; Stafford, J., “Big tobacco ‘pull out all stops’ for a landmark example: the Burswood Casino case,” Australasian Medical Journal 4(12): 645-654, [December 2011].
Webster, P.C., “Tobacco control measures under industry assault,” Canadian Medical Association Journal [Online ahead of print], October 24, 2011.
Fooks, G.J.; Gilmore, A.B.; Smith, K.E.; Collin, J.; Holden, C.; Lee, K., “Corporate social responsibility and access to policy elites: an analysis of tobacco industry documents,” PLoS Medicine 8(8): 1-12, August 2011.
Gonzalez, M.; Green, L.W.; Glantz, S.A., “Through tobacco industry eyes: civil society and the FCTC process from Philip Morris and British American Tobacco’s perspectives,” Tobacco Control [Online ahead of print], June 2, 2011.
Smith, P.; Bansal-Travers, M.; O’Connor, R.; Brown, A.; Banthin, C.; Guardino-Colket, S.; Cummings, K.M., “Correcting over 50 years of tobacco industry misinformation,” American Journal of Preventive Medicine40(6): 690-698, June 2011.
Gruning, T.; Weishaar, H.; Collin, J.; Gilmore, A.B., “Tobacco industry attempts to influence and use the German government to undermine the WHO Framework Convention on Tobacco Control,” Tobacco Control 21(1): 30-38, January 2011.
Schneider, N.K.; Sebrie, E.M.; Fernandez, E., “The so-called ‘Spanish model’- tobacco industry strategies and its impact in Europe and Latin America,” BMC Public Health 11: 907 , 2011.
Hatsukami, D.K.; Stepanov, I.; Hecht, S.S., “Major tobacco companies have technology to reduce carcinogen levels but do not apply it to popular smokeless tobacco products,” Tobacco Control [Online ahead of print], October 7, 2010.
Ling, P.M.; Haber, L.A.; Wedl, S., “Branding the rodeo: a case study of tobacco sports sponsorship,” American Journal of Public Health 100(1): 32-41, January 2010.
Smith, K.E.; Gilmore, A.B.; Fooks, G., “Tobacco industry attempts to undermine Article 5.3 and the ”good governance” trap,” Tobacco Control 18(6): 509-511, December 2009.
Malone, R.E., “On tobacco industry cultural appropriation,” Tobacco Control 18(6): 425-426, December 2009.
Glantz, S.A.; Mamudu, H.M.; Otanez, M.G., “Tobacco companies’ use of developing countries’ economic reliance on tobacco to lobby against global tobacco control: the case of Malawi,” American Journal of Public Health 99(10), October 2009.
Cortese, D.K.; Lewis, M.J.; Ling, P.M., “Tobacco industry lifestyle magazines targeted to young adults,” Journal of Adolescent Health45(3):268-280, September 2009.
Stanton, C.; Barnes, R.; Glantz, S.A., “Tobacco control in Maine, 1979-2009: the power of strategic collaboration,” San Francisco: Center for Tobacco Control Research and Education, August 2009.
Malone, R.E.; Smith, E.A., “Contact me soon!!! Confidential, risk-free opportunity!,” Tobacco Control 18(4): 249, August 2009.
Campbell, R.B.; Balbach, E.D., “Building alliances in unlikely places: progressive allies and the Tobacco Institute’s coalition strategy on cigarette excise taxes,” American Journal of Public Health 99(7), July 2009.
Kummerfeldt, C.E.; Barnoya, J.; Bero, L.A., “Philip Morris involvement in the development of an air quality laboratory in El Salvador,” Tobacco Control 18(3): 241-244, June 2009.
Dewhirst, T., “New directions in tobacco promotion and brand communication,” Tobacco Control 18(3): 161-162, June 2009.
Sullivan, S.; Barnes, R.L.; Glantz, S.A., “Shifting attitudes towards tobacco control in tobacco country: tobacco industry political influence and tobacco policy making in South Carolina,” San Francisco: Center for Tobacco Control Research and Education, March 2009.
Tung, G.J.; Hendlin, Y.H.; Glantz, S.A., “Competing initiatives: a new tobacco industry strategy to oppose statewide clean indoor air ballot measures,” American Journal of Public Health 99(3): 430-439, March 2009.
Landman, A.; Glantz, S.A., “Tobacco industry efforts to undermine policy-relevant research,” American Journal of Public Health 99(1), January 1, 2009.
[n.a.], “Global voices: status report 2009 – rebutting the tobacco industry – winning smokefree air,” Global Smokefree Partnership, 2009.
Yang, J.S., Malone, R.E.; “”Working to shape what society’s expectations of us should be”: Philip Morris’s societal alignment strategy,” Tobacco Control17(6): 391-398, December 2008.
Tesler, L.E.; Malone, R.E., “Ethical conduct in public and private arenas: corporate philanthropy, lobbying, and public health policy,” American Journal of Public Health 98(12): 2123-2133, December 2008.
Muggli, M.E.; Lee, K.; Gan, Q.; Ebbert, J.O.; Hurt, R.D., “‘Efforts to reprioritise the agenda’ in China: British American Tobacco’s efforts to influence public policy on secondhand smoke in China,” PLOS Medicine5(12), December 2008.
MacKenzie, R.; Collin, J., “”A good personal scientific relationship”: Philip Morris scientists and the Chulabhorn Research Institute, Bangkok,” PLoS Medicine 5(12): 1737-1748, December 2008.
Daube, M.; Stafford, J.; Bond, L., “No need for nanny,” Tobacco Control 17(6):426-427, December 2008.
Smith, E.A.; Malone, R.E., “Philip Morris’s health information web site appears responsible but undermines public health,” Public Health Nursing25(6): 554-564, November-December, 2008.
Schneider, N.K.; Glantz, S.A., “”Nicotine Nazis strike again”: a brief analysis of the use of Nazi rhetoric in attacking tobacco control advocacy,” Tobacco Control 17(5): 291-296, October 2008.
Samet, J.M.; “Secondhand smoke: facts and lies,” Salud Publica de Mexico 50(5): 428-434, September-October, 2008.
Muggli, M.E.; Ebbert, J.O.; Robertson, C.; Hurt, R.D., “Waking a sleeping giant: the tobacco industry’s response to the polonium-210 issue,”American Journal of Public Health 98(9): 1643-1650, September 2008.
Mamudu, H.M.; Hammond, R.; Glantz, S.A., “Project Cerberus: tobacco industry strategy to create an alternative to the Framework Convention on Tobacco Control,” American Journal of Public Health 98(9): 1630-1642, September 2008.
Stevenson, T., Proctor, R.N.; “The secret and soul of Marlboro: Philip Morris and the origins, spread, and denial of nicotine freebasing,” American Journal of Public Health 98(7): 1184-1194, July 2008.
Barnes, R.L.; McCarthy, J; Glantz, S.A., “Tobacco Control in Hawai’i: progress in paradise,” San Francisco, CA: Center for Tobacco Control Research and Education, July 2008.
[n.a.], “Tobacco industry interference with tobacco control,” Geneva: World Health Organization (WHO), 2008.
Lum, K.; Glantz, S.A., “The defeat of Oregon’s Tobacco Tax Initiative in 2007,” San Francisco: Center for Tobacco Control Research and Education, May 2008.
Wayne, G.F.; Connolly, G.N.; Henningfield, J.E.; Farone, W.A., “Tobacco industry research and efforts to manipulate smoke particle size: implications for product regulation,” Nicotine and Tobacco Research 10(4): 613-625, April 2008.
Hendlin, Y.H.; Barnes, R.; Glantz, S.A., “Tobacco control in transition: public support and governmental disarray in Arizona 1997-2007,” San Francisco: Center for Tobacco Control Research and Education, January 2008.
Rabinoff, M.; Caskey, N.; Rissling, A.; Park, C., “Pharmacological and chemical effects of cigarette additives,” American Journal of Public Health97(11): 1981–1991, November 2007.
Tong, E.K.; Glantz, S.A., “Tobacco industry efforts undermining evidence linking secondhand smoke with cardiovascular disease,” Circulation116(16): 1845-1854, October 16, 2007.
Glantz, S.A.; Barnes, R.L., “Endotoxins in tobacco smoke: shifting tobacco industry positions,” Nicotine & Tobacco Research 9(10): 995-1004, October 2007.
Schick, S.F.; Glantz, S., “Concentrations of the carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone in sidestream cigarette smoke increase after release into indoor air: results from unpublished tobacco industry research,” Cancer Epidemiology, Biomarkers & Prevention16(8): 1547-1553, August 2007.
Guardino, S.D.; Daynard, R.A., “Tobacco industry lawyers as ‘disease vectors’,” Tobacco Control 16(4): 224-228, August 2007.
Schick, S.F.; Glantz, S.A., “Old ways, new means: tobacco industry funding of academic and private sector scientists since the Master Settlement Agreement,” Tobacco Control 16(3): 157-164, June 1, 2007.
Apollonio, D.E.; Bero, L.A., “The creation of industry front groups: the tobacco industry and “Get Government Off Our Back,” American Journal of Public Health [Online ahead of print], January 31, 2007.
Wander, N.; Malone, R.E., “Making Big Tobacco give in: you lose, they win,” American Journal of Public Health 96(11): 2048–2054, November 2006.
Smith, E.A.; Malone, R.E., “‘We will speak as the smoker’: the tobacco industry’s smokers’ rights groups,” European Journal of Public Health[Online ahead of print], October 25, 2006.
Barnes, R.L.; Hammond, S.K.; Glantz, S.A., “The tobacco industry’s role in the 16 Cities Study of Secondhand Tobacco Smoke: do the data support the stated conclusions?,” Environmental Health Perspectives, August 29, 2006.
Lopipero, P.A.; Bero, L.A., “Tobacco interests or the public interest: 20 years of industry strategies to undermine airline smoking restrictions,” Tobacco Control 15(4): 323-332, August 2006.
Friedman, L.C., “Tobacco industry use of judicial seminars to influence rulings in products liability litigation,” Tobacco Control 15(2): 120-124, April 2006.
Bornhäuser, A.; McCarthy, J.; Glantz, S.A., “German tobacco industry’s successful efforts to maintain scientific and political respectability to prevent regulation of secondhand smoke,” Tobacco Control 15(2): e1, April 2006.
Hammond, D.; Collishaw, N.E.; Callard, C., “Secret science: tobacco industry research on smoking behaviour and cigarette toxicity,” The Lancet367(9512): 781-787, March 4, 2006.
Barnoya, J.; Glantz, S.A., “The tobacco industry’s worldwide ETS consultants project: European and Asian components,” European Journal of Public Health 16(1): 69-77, February 2006.
Leavell, N.R.; Muggli, M.E.; Hurt, R.D.; Repace, J., “Blowing smoke: British American Tobacco’s air filtration scheme,” BMJ 332: 227-229, January 2006.
Gruning, T.; Gilmore, A.B.; McKee, M., “Tobacco industry influence on science and scientists in Germany,” American Journal of Public Health 96(1), January 1, 2006.
Schick, S.; Glantz, S., “Scientific analysis of second-hand smoke by the tobacco industry, 1929-1972,” Nicotine & Tobacco Research 7(4): 591- 612, August 2005.
Baba, A.; Cook, D.M.; McGarity, T.O., “Legislating ‘sound science’: the role of the tobacco industry,” American Journal of Public Health 95(S1): S20, 2005.
Friedman, L.C.; Daynard, R.A.; Banthin, C.N., “How tobacco-friendly science escapes scrutiny in the courtroom,” American Journal of Public Health 95(S1): S16-S20, 2005.
Schick, S.; Glantz, S., “Philip Morris toxicological experiments with fresh sidestream smoke: more toxic than mainstream smoke,” Tobacco Control14: 396-404, 2005.
Torrijos, R.; Glantz, S.A., “Tobacco control policy making in Montana 1979-2005: falling off the horse at the finish line,” San Francisco, CA: University of California, San Francisco, Center for Tobacco Control Research and Education, November 1, 2005.
Bero, L., “Tobacco industry manipulation of research,” Public Health Reports 120(2): 200-208, March/April 2005. Abstract Unavailable.
Givel, M.”Tobacco industry opposition to designating environmental tobacco smoke through e-codes,” Journal of Public Health Policy 26(1): 75-89, 2005.
Tong, E.K.; England, L.; Glantz, S.A., “Changing conclusions on secondhand smoke in a Sudden Infant Death Syndrome review funded by the tobacco industry,” Pediatrics 115(3): 356-366, March 2005.
Pan, J.; Barbeau, E.M.; Levenstein, C.; Balbach, E.D., “Smoke-free airlines and the role of organized labor: a case study,” American Journal of Public Health 95(3): 398-404, March 2005.
Garne, D.; Watson, M.; Chapman, S.; Byrne, F., “Environmental tobacco smoke research published in the journal Indoor and Built Environment and associations with the tobacco industry,” The Lancet 365(9461): 804-809, February 26, 2005.
Diethelm, P.A.; Rielle, J.; McKee, M., “The whole truth and nothing but the truth? The research that Philip Morris did not want you to see,” The Lancet, November 12, 2004.
Bero, L.A.; Glantz, S.; Hong, M-K, “The limits of competing interest disclosures,” PRE-PUBLISHED, Tobacco Control, tc7666 (Module 1), November 29, 2004.
Hirschhorn, N., “Research reports and publications based on tobacco industry documents, 1991-2004,” Norbert Hirschhorn, MD, November 2004.
Mandel, L.L.; Glantz, S.A., “Hedging their bets: tobacco and gambling industries work against smoke-free policies,” Tobacco Control 13(3): 268-276, September 2004.
Welle, J.R.; Ibrahim, J.K.; Glantz, S.A., “Tobacco control policy making in North Dakota: a tradition of activism,” San Francisco: Center for Tobacco Control Research and Education, June 2004.
Nixon, M.L.; Mahmoud, L.; Glantz, S.A., “Tobacco industry litigation to deter local public health ordinances: the industry usually loses in court,” Tobacco Control 13(1): 65-73, March 2004.
Drope, J.; Glantz, S., “British Columbia capital regional district 100% smokefree bylaw: a successful public health campaign despite industry opposition,” Tobacco Control 12(3): 264-268, September 2003.
Tsoukalas, T.; Glantz, S.A., “The Duluth clean indoor air ordinance: problems and successes in fighting the tobacco industry at the local level in the 21st century,” American Journal of Public Health 93(8): 1214-1221, August 2003.
Muggli, M.E.; Hurt, R.D.; Blanke, D., “Science for hire: a tobacco industry strategy to influence public opinion on secondhand smoke,” Nictoine & Tobacco Research 5(3): 303-314, June 2003.
Trochim, W.M.K.; Stillman, F.A.; Clark, P.I.; Schmitt, C.L., “Development of a model of the tobacco industry’s interference with tobacco control programmes,” Tobacco Control 12(2): 140-147, June 2003.
Bryan-Jones, K.; Bero, L.A., “Tobacco industry efforts to defeat the Occupational Safety and Health Administration indoor air quality rule,” American Journal of Public Health 93(4): 585-592, April 2003.
Hirschhorn, N.; Bialous, S.A., “Second hand smoke and risk assessment: what was in it for the tobacco industry?,” Tobacco Control 10(4): 375-382, December 2001.
Ong, E.K.; Glantz, S.A., “Constructing ‘sound science’ and ‘good epidemiology’: tobacco, lawyers, and public relations firms,” American Journal of Public Health 91(11): 1749-1757, November 2001.
Samet, J.M.; Burke, T.A., “Turning science into junk: the tobacco industry and passive smoking,” American Journal of Public Health91(11): 1742-1744, November 2001.
Yach, D.; Aguinaga Bialous, S., “Junking science to promote tobacco,” American Journal of Public Health 91(11): 1745-1748, November 2001.
Muggli, M.E., Forster, J.L., Hurt, R.D., Repace, J.L., “The smoke you don’t see: uncovering tobacco industry scientific strategies aimed against environmental tobacco smoke policies,” American Journal of Public Health 91(9): 1419-1423, September 2001.
Ritch, W.A.; Begay, M.E., “Strange bedfellows: the history of collaboration between the Massachusetts Restaurant Association and the tobacco industry,” American Journal of Public Health 91(4): 598-603, April 2001.
Hirschhorn, N.; Bialous, S.A.; Shatenstein S., “Philip Morris’ new scientific initiative: an analysis,” Tobacco Control 10(3):247-252, 2001.
Drope, J.; Chapman, S., “Tobacco industry efforts at discrediting scientific knowledge of environmental tobacco smoke: a review of internal industry documents,” J Epidemiol Community Health 55(8): 588-594. 2001
Ong, E.K.; Glantz, S.A., “Tobacco industry efforts subverting International Agency for Research on Cancer’s second-hand smoke study,” Lancet 355(9211): 1253-1259, April 8, 2000.
Rampton, S.; Stauber, J., “How Big Tobacco Helped Create “The Junkman,” PR Watch 7(3), Third Quarter 2000.
Barnes, D.E.; Bero, L.A., “Why review articles on the health effects of passive smoking reach different conclusions,” Journal of the American Medical Association, 279(19): 1566-1570, May 20, 1998.
Barnes, D.E.; Bero, L.A., “Scientific quality of original research articles on environmental tobacco smoke,” Tobacco Control 6(1): 19-26, 1997.
Barnes, D.E.; Bero, L.A., “Industry-funded research and conflict of interest: an analysis of research sponsored by the tobacco industry through the Center for Indoor Air Research,” J Health Politics Policy Law21(3): 515-542, 1996.
Barnes, D.E.; Hanauer, P.; Slade, J.; Bero, L.A.; Glantz, S.A., “Environmental tobacco smoke. The Brown and Williamson documents,” Journal of the American Medical Association 274(3): 248-253, July 19, 1995.
Bero, L.A.; Glantz, S.A.; Rennie, D., “Publication bias and public health policy on environmental tobacco smoke,” Journal of the American Medical Association 272(2): 133-136, July 13, 1994.
Bero L.A.; Glantz S.A., “Tobacco industry response to a risk assessment of environmental tobacco smoke,” Tobacco Control 2: 103-113, 1993.